Joel Hyman, MD
Dermatology · The Woodlands, TXNPI 1881774818
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $15,109 of the $22,403 with a category attached, or 67.4%. 32 manufacturers reported payments, led by Galderma Laboratories, L.p. at 26.2% of the total. Reporting peaked in 2019 at $7,634 and has fallen 52.9% since, to $3,597 in 2025.
Across 718 payments — averaging $31.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$6K
- Regeneron Healthcare Solutions, Inc.$3K
- AbbVie$2K
- Johnson & Johnson$2K
- Lilly USA, LLC$2K
- Novartis$1K
- plus $6K from 26 others
What the payments were for
- Consulting fees$1,8008%
- Speaking & faculty fees$5,00022%
- Food & beverage$15,10967%
- Education$4942%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 27 | $5,862 |
| Regeneron Healthcare Solutions, Inc. | 39 | $3,313 |
| AbbVie(2 entities) | 119 | $2,417 |
| Johnson & Johnson | 91 | $2,000 |
| Lilly USA, LLC | 87 | $1,634 |
| Novartis | 68 | $1,398 |
| Sun Pharmaceutical Industries Inc. | 33 | $900 |
| Pfizer | 71 | $713 |
| UCB, Inc. | 25 | $683 |
| Sanofi | 22 | $645 |
| Amgen | 35 | $621 |
| Incyte Corporation | 19 | $390 |
| LEO Pharma Inc. | 13 | $288 |
| E.r. Squibb & Sons, L.L.C. | 13 | $272 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 13 | $207 |
| Arcutis Biotherapeutics, Inc. | 8 | $163 |
| Boehringer Ingelheim | 7 | $146 |
| Janssen Scientific Affairs, LLC | 1 | $122 |
| Hill Dermaceuticals, Inc. | 4 | $120 |
| Revance Therapeutics, Inc. | 1 | $109 |
| Bristol Myers Squibb | 6 | $96 |
| EPI Health, LLC | 3 | $61 |
| Sanofi US Services Inc. | 1 | $37 |
| Botanix SB Inc | 2 | $37 |
| Dermavant Sciences, Inc. | 2 | $28 |
| Genentech USA, Inc. | 2 | $25 |
| Almirall LLC | 1 | $23 |
| Springworks Therapeutics, Inc. | 1 | $21 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| Organon | 1 | $18 |
| Dermira, Inc. | 1 | $17 |
| DUSA Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,403 in reported general payments places this provider in the 85th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 14 | $109,710 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 13 | $96,804 |
| Fluorouracil | 55 | $3,239 |
| Metronidazole | 55 | $2,998 |
| Clobetasol Propionate | 92 | $2,920 |
| Doxycycline Monohydrate | 106 | $2,033 |
| Hydroxychloroquine Sulfate | 28 | $1,600 |
| Tacrolimus | 16 | $1,525 |
| Triamcinolone Acetonide | 128 | $1,006 |
| Ketoconazole | 74 | $1,006 |
| ValacyclovirValacyclovir Hcl | 36 | $573 |
| Mometasone Furoate | 23 | $547 |
| Betamethasone Dipropionate | 14 | $538 |
| MethotrexateMethotrexate Sodium | 18 | $498 |
| Clindamycin Phosphate | 18 | $422 |
Paid to pharmacies, not to this prescriber.
Other dermatology in The Woodlands
- Edward LainAustin$2.5M
- William CragunSan Antonio$2.2M
- Alpesh DesaiHouston$1.6M
- Craig TellerBellaire$1.3M
- Jennifer CatherDallas$1.3M
- Emily BeckerSan Antonio$1.2M
- Ross RaduskyDallas$1.2M
- Joseph MerolaDallas$1.2M
- Daniel CarrascoAustin$1.1M
- Dale SchaeferAustin$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.